Sumitomo Mitsui Trust Group Inc. Purchases 21,402 Shares of Astera Labs, Inc. $ALAB

Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 7.9% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 293,853 shares of the company’s stock after purchasing an additional 21,402 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Astera Labs were worth $32,206,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Astera Labs by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after buying an additional 84,365 shares in the last quarter. State Street Corp raised its holdings in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after acquiring an additional 760,358 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after acquiring an additional 104,935 shares in the last quarter. Fred Alger Management LLC lifted its stake in Astera Labs by 25.5% in the fourth quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after acquiring an additional 393,250 shares during the period. Finally, Morgan Stanley lifted its stake in Astera Labs by 33.0% in the fourth quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock worth $321,818,000 after acquiring an additional 480,009 shares during the period. 60.47% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have commented on ALAB. Royal Bank Of Canada raised their target price on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Citigroup cut shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Needham & Company LLC increased their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Bank of America lifted their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Finally, Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $275.75.

Astera Labs Stock Down 12.3%

NASDAQ ALAB opened at $362.05 on Tuesday. The firm has a market cap of $62.06 billion, a PE ratio of 244.63, a price-to-earnings-growth ratio of 4.65 and a beta of 3.66. The company has a 50 day moving average price of $339.10 and a 200 day moving average price of $216.30. Astera Labs, Inc. has a 52 week low of $88.18 and a 52 week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same period last year, the firm earned $0.33 earnings per share. Astera Labs’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 1.88 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Bethany Mayer sold 686 shares of the company’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total transaction of $270,997.44. Following the transaction, the director directly owned 5,550 shares of the company’s stock, valued at $2,192,472. This represents a 11.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $1,577,250.00. Following the completion of the sale, the director owned 57,466 shares of the company’s stock, valued at approximately $25,859,700. This trade represents a 5.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 2,040,691 shares of company stock worth $507,675,380. Company insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.